中图分类号R95 文献标志码A 文章编号 1001-0408(2025)08-0908-06

    DOI 10.6039/j.issn.1001-0408.2025.08.03

    International experience and enlightenment of patient engagement in drug regulation

    WU Jingjing'2， ZENG Kaixin'2，YANG Yufeil2， TIAN Mengyan'， DONG Fangzheng'， ZHANG Yimeng'，LI ， MAO Ningying'2(1. School of International Medicine Business， China Pharmaceutical University， Nanjing 2ll98， China； 2. Research Center of National Drug Policy amp; Ecosystem， China Pharmaceutical University，Nanjing ，China)

    ABSTRACTOBJECTIVEToprovide suggestions forimproving the path andsystemconstructionofpatientengagement indrug regulation in China.METHODS Byreviewinginitiatives andexperiences from theUnitedStates(U.S.)，EuropeanUnion(EU)， and Japaninpromoting patientengagement，this studysummarizestherolesandcontributions of patientsintheentiredrug regulatory processintermationallyCombining China'scurrent progressandchallengesinpatientengagementspecificproposalsare formulated to refine regulatory pathways andinstitutional systems.RESULTSamp;CONCLUSIONS Withgrowing global emphasis on patientengagement asaregulatorystrategy ......